| 0 (0%) | 10-15 12:18 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 122.04 |
1-year : | 142.54 |
| Resists | First : | 104.48 |
Second : | 122.04 |
| Pivot price | 98.21 |
|||
| Supports | First : | 98.01 |
Second : | 94.01 |
| MAs | MA(5) : | 97.23 |
MA(20) : | 98.72 |
| MA(100) : | 97.28 |
MA(250) : | 102.23  |
|
| MACD | MACD : | -1 |
Signal : | -1 |
| %K %D | K(14,3) : | 54 |
D(3) : | 29.2 |
| RSI | RSI(14): 54 |
|||
| 52-week | High : | 114.72 | Low : | 89.22 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ZBH ] has closed below upper band by 12.4%. Bollinger Bands are 17.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 98.91 - 99.38 | 99.38 - 99.81 |
| Low: | 93.46 - 94 | 94 - 94.5 |
| Close: | 97.46 - 98.37 | 98.37 - 99.2 |
Tue, 14 Oct 2025
Zimmer Biomet (ZBH): Exploring the Company’s Valuation After Recent Share Price Uptick - simplywall.st
Tue, 14 Oct 2025
Piper Sandler Keeps Their Hold Rating on Zimmer Biomet Holdings (ZBH) - The Globe and Mail
Mon, 13 Oct 2025
Piper Sandler Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating - 富途牛牛
Mon, 13 Oct 2025
BTIG Raises Price Target for Zimmer Biomet Holdings (ZBH) to $12 - GuruFocus
Mon, 13 Oct 2025
Johnson Investment Counsel Inc. Sells 22,675 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Mon, 13 Oct 2025
Zimmer Biomet Holdings (ZBH) Investor Outlook: Exploring A Potential 16.72% Upside - DirectorsTalk Interviews
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 198 (M) |
| Shares Float | 198 (M) |
| Held by Insiders | 0.1 (%) |
| Held by Institutions | 98.8 (%) |
| Shares Short | 6,800 (K) |
| Shares Short P.Month | 5,810 (K) |
| EPS | 4.09 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 63.29 |
| Profit Margin | 10.5 % |
| Operating Margin | 19.5 % |
| Return on Assets (ttm) | 4.3 % |
| Return on Equity (ttm) | 6.5 % |
| Qtrly Rev. Growth | 7 % |
| Gross Profit (p.s.) | 28.16 |
| Sales Per Share | 39.52 |
| EBITDA (p.s.) | 13.07 |
| Qtrly Earnings Growth | -34.8 % |
| Operating Cash Flow | 1,660 (M) |
| Levered Free Cash Flow | 1,290 (M) |
| PE Ratio | 24.55 |
| PEG Ratio | 0 |
| Price to Book value | 1.59 |
| Price to Sales | 2.54 |
| Price to Cash Flow | 12.01 |
| Dividend | 0.23 |
| Forward Dividend | 0 |
| Dividend Yield | 0.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|